← @biotechinvstr

$CRSP

看空2023-10-27
各周期结果✓ 命中-12.5%
1d
-3.4%
5d
+7.4%
21d
-12.5%
原帖
Vk · 2023-10-27

$CRSP efficacy on VOC freedom worsening over time - 7/44 patients with VOCs as per the Adcomm docs vs 3/35 at EHA Comp to BLUE Lovo-cel with 1/27 patients experienced VOEs with 24 month follow up https://t.co/R8auWKDffg

在 X 查看 ↗